While Wegovy for weight loss significantly reduces appetite, it doesnt fully suppress hunger immediately
[Wegovy]: An FDA-approved injectable semaglutide specifically for chronic weight management
Common themes from clinical experience and published patient surveys: Most patients notice reduced hunger and earlier fullness within the first 2 to 4 weeks
Animal Toxicology Studies Animal toxicology studies tested doses from 0.0027 mg/lb to 9.1 mg/lb via intraperitoneal, intramuscular, intravenous, and oral routes for up to 6 weeks, finding: No acute toxic or lethal dose No gross or histologic toxicity in major organs No hepatotoxicity or nephrotoxicity Negative Ames test (no mutagenicity) Negative chromosomal aberration tests (no genotoxicity) No teratogenicity in rat pregnancy studies No local injection site irritation The LD1 (minimum lethal dose) could not be achieved despite aggressive testing
Risk to Children and Pets: Curious children and pets are particularly vulnerable to improperly discarded sharps
If you experience any unusual symptoms, such as an allergic reaction or abdominal discomfort, our healthcare providers are readily available to help identify and manage any concerns promptly
